Lifecore Biomedical Announces Special Stockholder Meeting
17. Januar 2025 17:24 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Yseop Kicks Off 2025 by Strengthening Its Leadership in Generative AI for Life Sciences
15. Januar 2025 09:00 ET
|
Yseop
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Yseop, a global leader in Generative AI for life sciences, is starting 2025 with a series of achievements and strategic collaborations that underscore its...
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
09. Januar 2025 17:17 ET
|
kneat.com, inc.
Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes.
Next-generation RNA company Inverna Therapeutics launched by Argobio and University of Southern Denmark
07. Januar 2025 04:00 ET
|
AKAMPION
Novel paradigm for therapeutics based on RNA splicing modulationLead program in Huntington’s disease Denmark – Odense – 07/01/2025 – Inverna Therapeutics, a novel Danish biotech company at the...
ON Partners Strengthens Healthcare and Life Sciences Expertise with Strategic Investment & Expansion
06. Januar 2025 09:08 ET
|
ON Partners
CLEVELAND, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ON Partners, a pure-play retained executive search firm that builds diverse C-level and board leadership teams, has expanded its focus in the healthcare...
Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
20. Dezember 2024 07:30 ET
|
Quantum BioPharma
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval...
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
17. Dezember 2024 09:00 ET
|
Alira Health
Alira Health announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor.
Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia
12. Dezember 2024 06:59 ET
|
Sobi, Inc.
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration...
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
19. November 2024 09:00 ET
|
Biopharma Leaders of Color, Inc.
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
2024 BioTech Breakthrough Awards Program Celebrates Groundbreaking Biotechnology Innovators Around the World
19. November 2024 08:00 ET
|
BioTech Breakthrough
LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...